Advantage Business Media

Labroots Announces Agenda for its 7th Annual Drug Discovery & Development Virtual Event on February 21, 2024

Retrieved on: 
Thursday, February 15, 2024

YORBA LINDA, Calif., Feb. 15, 2024 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual and hybrid events and webinars, today announced its 7th annual event in the Drug Discovery & Development Virtual Event Series. Hosted on February 21st and free to attend, attendees will experience the forefront of pharmaceutical innovation joining industry and academic leaders from around the world debating the latest, insightful scientific breakthroughs in this ever-evolving field.

Key Points: 
  • Focusing from pre-clinical development to clinical development, advances in the field of drug discovery and development will be explored shaping current and future challenges in drug research
    YORBA LINDA, Calif., Feb. 15, 2024 /PRNewswire-PRWeb/ -- Labroots , the leading scientific social networking website offering premier, interactive virtual and hybrid events and webinars, today announced its 7th annual event in the Drug Discovery & Development Virtual Event Series .
  • The 2024 informative agenda covers a range of sessions spanning areas including Emerging Modalities in Drug Discovery and Preclinical Development, New Methods in Pharmacogenomics, and Biomarker Applications.
  • Use the hashtag #LRdrug to follow the conversation and connect with other members of the global Drug Discovery & Development community!
  • Follow @DrugDiscoveryLR on Twitter and @DrugDiscoveryandDevelopment on Facebook to connect with our specialist Drug Discovery & Development writers and stay up to date with the latest Trending News in Drug Discovery & Development.

Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Development Products

Retrieved on: 
Thursday, February 8, 2024

Agilent Technologies Inc. (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year.
  • These accolades highlight Agilent’s commitment to innovation and excellence in drug discovery and development.
  • The Agilent xCELLigence RTCA HT-BioTek BioSpa 8 – Screening Model was voted Best New Drug Discovery & Development Product of 2023.
  • The Drug Discovery & Development Webinar of the Year was co-produced between Agilent and Dr. Agapitos Patakas, Chief Scientific Officer, Antibody Analytics.

Oliver Asmus Joins DAS42 as Field Chief Technology Officer to Drive Data Modernization Success

Retrieved on: 
Tuesday, February 6, 2024

DAS42 , a leading data consultancy, today announced it has welcomed former Slalom executive Oliver Asmus as Field Chief Technology Officer to drive innovation at DAS42 and lead the consulting organization to help customers become genuine data-driven entities.

Key Points: 
  • DAS42 , a leading data consultancy, today announced it has welcomed former Slalom executive Oliver Asmus as Field Chief Technology Officer to drive innovation at DAS42 and lead the consulting organization to help customers become genuine data-driven entities.
  • Asmus will work closely with, and report to, CEO Frank Farrall and lead the charge on evolving DAS42’s data analytic offerings.
  • Asmus has strong experience implementing data-driven solutions in the media and entertainment industry and supporting the adoption and optimization of Snowflake Data Cloud.
  • “I’m honored to join DAS42 to help drive the technology strategy forward and enhance our innovative data solutions and Snowflake offerings,” said Asmus.

3D Optical Microscope Market to grow by USD 113.04 million from 2022 to 2027, Increasing funding for RandD to drive growth -Technavio

Retrieved on: 
Monday, February 5, 2024

They are used in Materials Science for high-resolution imaging of materials' surface structures and properties.

Key Points: 
  • They are used in Materials Science for high-resolution imaging of materials' surface structures and properties.
  • In Atomic, Molecular, and Optical Physics, they enable precise visualization and analysis of atomic and molecular structures.
  • Moreover, 3D Optical Microscopes play a significant role in 3D Scanning and Image Segmentation for creating detailed 3D models and analyzing complex images.
  • What are the key data covered in this 3D Optical Microscope Market report?

New CFO Named at Advantage Media

Retrieved on: 
Tuesday, January 30, 2024

CHARLESTON, S.C., Jan. 30, 2024 /PRNewswire/ -- Renée Barnstone has been named Chief Financial Officer for Advantage Media, effective January 2, 2024.

Key Points: 
  • Signaling Next Stage of Growth for Leading Business Book Publisher and Authority Company, operating through Advantage Media and Forbes Books.
  • CHARLESTON, S.C., Jan. 30, 2024 /PRNewswire/ -- Renée Barnstone has been named Chief Financial Officer for Advantage Media, effective January 2, 2024.
  • "I'm thrilled to partner with Renée to help lead the charge as we continue to advance our growth and profitability goals," said Advantage Media Founder & CEO, Adam Witty.
  • With the arrival of Barnstone, John Witty, who has been serving as Interim Chief Financial Officer, will transition to a Senior Advisor role at Advantage Media.

Global Automated Blood Tube Labelers and Specimen Transport Boxes Strategic Research Report 2024 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 19, 2024

The "Automated Blood Tube Labelers and Specimen Transport Boxes - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Automated Blood Tube Labelers and Specimen Transport Boxes - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
  • This report focuses on Automated Blood Tube Labelers and Specimen Transport Boxes, offering insights into the Global Key Competitors' Percentage Market Share in 2022 and categorizing their Competitive Market Presence as strong, active, niche, or trivial.
  • It introduces Automated Blood Tube Labelers and Specimen Transport Boxes, providing an overview of these essential laboratory equipment pieces.
  • The Automated Blood Tube Labelers and Specimen Transport Boxes market in the U.S. is estimated at US$101 Million in the year 2022.

Global Laboratory Refrigerators and Ovens Strategic Analysis Report 2023: Market to Reach $2.5 Billion by 2030 - Rising R&D Investments by Pharmaceutical & Biopharmaceutical Industry to Fuel Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 10, 2024

The global market for Laboratory Refrigerators and Ovens estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$2.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2022-2030.

Key Points: 
  • The global market for Laboratory Refrigerators and Ovens estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$2.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2022-2030.
  • The report introduces Laboratory Refrigerators & Freezers, focusing on the types and categories within these essential laboratory equipment pieces.
  • The global market outlook for Laboratory Refrigerators, Freezers, and Ovens is discussed, shedding light on trends and growth prospects.
  • The Laboratory Refrigerators and Ovens market in the U.S. is estimated at US$535.8 Million in the year 2022.

Nalu Medical, Inc., Announces Positive Results of US Spinal Cord Stimulation Clinical Study in Pain Physician Journal

Retrieved on: 
Wednesday, November 29, 2023

Today the company announces publication of the SCS nPower™ US clinical study in the Pain Physician Journal that reports on clinical outcomes related to the use of the Nalu SCS System to treat patients suffering from chronic intractable pain of the of trunk and/or limbs, including unilateral or bilateral pain.

Key Points: 
  • Today the company announces publication of the SCS nPower™ US clinical study in the Pain Physician Journal that reports on clinical outcomes related to the use of the Nalu SCS System to treat patients suffering from chronic intractable pain of the of trunk and/or limbs, including unilateral or bilateral pain.
  • The SCS nPower US clinical study was a prospective, post-market observational study conducted at 15 comprehensive pain centers in the US.
  • The Nalu Neurostimulation System was evaluated in 35 subjects with chronic low back and leg pain from baseline to 3 months.
  • Highlights of the results include:
    The wearable Therapy Disc was reported by all patients to be comfortable and easy to use.

Haymarket Media US Announces Key Leadership Transitions

Retrieved on: 
Tuesday, November 14, 2023

His proficiency in financial management, combined with his understanding of the industry’s dynamics, positions him as a valuable addition to the Haymarket Media US leadership team.

Key Points: 
  • His proficiency in financial management, combined with his understanding of the industry’s dynamics, positions him as a valuable addition to the Haymarket Media US leadership team.
  • “I am very excited and honored to join Haymarket Media, home to many iconic brands,” Borella said.
  • “We look forward to the valuable insights and leadership he will bring to our team.”
    In addition to naming a new CFO, Haymarket is announcing leadership changes within its PRIHealthcare Solutions (PRI) and Business Media Group divisions.
  • “I am confident that the collective expertise, vision, and dedication of our leadership team will continue to drive Haymarket Media’s success.”

From Magento to Maergo: Tech Leader Mark Lavelle Discusses Talks Strategy in Challenging Times on DCKAP's Driven Podcast

Retrieved on: 
Wednesday, November 29, 2023

AUSTIN, Texas, Nov. 29, 2023 /PRNewswire/ -- In a candid conversation on the DCKAP Driven podcast, Mark Lavelle, celebrated for steering Magento and now at the helm of Maergo and Deep Lake Capital, shares his playbook on leadership, investment, and the magic of community in business. Hosted by Karthik Chidambaram, DCKAP's founder and CEO, the dialogue unveils Lavelle's pivotal decisions during his Magento tenure, his innovative approach at Maergo, and his philosophy on personal and venture investments.

Key Points: 
  • Lavelle demystifies leadership, emphasizing the importance of recognizing one's limits and the bravery required to bridge knowledge gaps.
  • His strategy involves rallying a robust team and igniting their enthusiasm to drive collective success.
  • Lavelle imparts a vital lesson for entrepreneurs, especially in today's turbulent market, stressing the essence of focus, passion, and customer-centricity.
  • The DCKAP Driven Podcast is an audio and video show that explores leaders' stories, digital journeys, and insights on trends in B2B and distribution.